OCUL Stock In Spotlight After Q2 Loss Comes In Narrower Than Estimated – A Look At Key Highlights

Ocular's Q2 loss was narrower than estimated.

Ocular's total cash and cash equivalents stood at $598.6 million at end of Q2.

Cash runway is expected to last until 2028.